 | Up a level |
Leon Betancourt, A; Hoepner, Robert; Hammer, Helly; Chan, Andrew; Salmen, Anke (2024). Sex- and age-related shift of relapse phenotypes in a cohort of relapsing multiple sclerosis patients: Post hoc analysis from the OPERA phase 3 trials. European journal of neurology, 31(10), e16396. Wiley 10.1111/ene.16396
Berger, Charlotte; Hammer, Helly; Costa, Marino; Lowiec, Pawel; Yagensky, Andriy; Scutelnic, Adrian; Antonenko, Kateryna; Biletska, Olga; Karaszewski, Bartosz; Sarikaya, Hakan; Zdrojewski, Tomasz; Klymiuk, Anastasiia; Bassetti, Claudio LA; Yashchuk, Natalia; Chwojnicki, Kamil; Arnold, Marcel; Saner, Hugo; Heldner, Mirjam R (2024). Baseline characteristics, reperfusion treatment secondary prevention and outcome after acute ischemic stroke in three different socioeconomic environments in Europe. (In Press). European stroke journal, p. 23969873241245518. Sage 10.1177/23969873241245518
Peycheva, Marieta; Padlina, Giovanna; Genceviciute, Kotryna; Krasteva, Marina P.; Boronylo, Anna; Goeldlin, Martina B.; Müller, Madlaine; Wenz, Elena S.; Müller, Mandy D.; Hammer, Helly; Bücke, Philipp; Bigi, Sandra; Goeggel Simonetti, Barbara; Hoffmann, Angelika; Umarova, Roza M.; Pilgram-Pastor, Sara; Gralla, Jan; Mordasini, Pasquale; Antonenko, Kateryna and Heldner, Mirjam R. (2024). Baseline characteristics and outcome of stroke patients after endovascular therapy according to previous symptomatic vascular disease and sex. Frontiers in neurology, 15, p. 1293905. Frontiers Media S.A. 10.3389/fneur.2024.1293905
Thränhardt, Pauline; Veselaj, Admirim; Friedli, Christoph; Wagner, Franca; Marti, Stefanie; Diem, Lara; Hammer, Helly; Radojewski, Piotr; Wiest, Roland; Chan, Andrew; Hoepner, Robert; Salmen, Anke (2024). Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse events. Therapeutic advances in neurological disorders, 17(17562864241237853) Sage 10.1177/17562864241237853
Diem, L; Ovchinnikov, A; Friedli, C; Hammer, H; Kamber, N; Chan, A; Salmen, A; Findling, O; Hoepner, R (2024). Efficacy and safety of ocrelizumab in patients with relapsing multiple sclerosis: real-world experience of two Swiss Multiple Sclerosis centers. Multiple Sclerosis and Related Disorders, 86 Elsevier 10.1016/j.msard.2024.105570
Friedli, Christoph; Krajnc, Nik; Hammer, Helly N; Marti, Stefanie; Zrzavy, Tobias; Evangelopoulos, Maria E; Kapsali, Ioanna; Rommer, Paulus; Berger, Thomas; Chan, Andrew; Bsteh, Gabriel; Hoepner, Robert (2024). Different lymphocyte counts of multiple sclerosis patients treated with ofatumumab and ocrelizumab: A retrospective observational study. Journal of central nervous system disease, 16(11795735241249644) Sage 10.1177/11795735241249644
Marti, Stefanie; Hoepner, Andreas G F; Hammer, Helly; Salmen, Anke; Chan, Andrew; Hoepner, Robert (2023). Socioeconomic and Regional Disparities in Industry-Sponsored Clinical Trials in Multiple Sclerosis. JAMA network open, 6(11), e2345619. American Medical Association 10.1001/jamanetworkopen.2023.45619
Léon Betancourt, Alejandro; Schwarzwald, Anina; Millonig, Alban; Oberholzer, Michael; Sabater, Lidia; Hammer, Helly; Kamber, Nicole; Diem, Lara; Chan, Andrew; Hoepner, Robert; Salmen, Anke; Friedli, Christoph (2023). Anti-Kelch-like protein 11 (KLHL11) antibody associated encephalitis -Two case reports and review of the literature. European journal of neurology, 30(6), pp. 1801-1814. Wiley 10.1111/ene.15758
Friedli, Christoph; Wagner, Franca; Hammer, Helly Noemi; Kamber, Nicole; Wiest, Roland; Diem, Lara; Chan, Andrew; Salmen, Anke; Hoepner, Robert (2023). Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients. Multiple sclerosis journal, 29(1), pp. 63-73. Sage 10.1177/13524585221122210
Hammer, H; Kamm, CP; Salmen, A; Hoepner, R (2023). "Comparable Efficacy of SARS-CoV-2 mRNA Vaccines (BNT162b2 and mRNA-1273) in Fingolimod-Treated Patients with Multiple Sclerosis". Biomedical journal of scientific & technical research, 50(1) Biomedical Research Network+ 10.26717/BJSTR.2023.50.007885
Diem, Lara; Schwarzwald, Anina; Friedli, Christoph; Hammer, Helly; Gomes-Fregolente, Livia; Warncke, Jan; Weber, Lea; Kamber, Nicole; Chan, Andrew; Bassetti, Claudio; Salmen, Anke; Hoepner, Robert (2022). Multidimensional phenotyping of the post-COVID-19 syndrome: A Swiss survey study. CNS neuroscience & therapeutics, 28(12), pp. 1953-1963. Wiley 10.1111/cns.13938
Diem, L; Evangelopoulos, M E; Karathanassis, D; Natsis, V; Kamber, N; Hammer, H; Friedli, C; Chan, A; Helbling, A; Penner, I K; Salmen, A; Walther, S; Stegmayer, K; Hoepner, R (2022). Hypogammaglobulinemia: A contributing factor to multiple sclerosis fatigue? Multiple Sclerosis and Related Disorders, 68, p. 104148. Elsevier 10.1016/j.msard.2022.104148
Hammer, H; Kamber, N; Pistor, M; Diem, L; Friedli, C; Chan, A; Hoepner, R; Salmen, A (2022). Ocrelizumab-related neutropenia: Effects of age, sex and bodyweight using the FDA Adverse Event Reporting System (FAERS). Multiple Sclerosis and Related Disorders, 65, p. 104015. Elsevier 10.1016/j.msard.2022.104015
Hammer, Helly; Kamber, Nicole; Friedli, Christoph; Hoepner, Robert; Diem, Lara; Chan, Andrew; Salmen, Anke (2022). [Primary CNS Vasculitis - An Overview]. Therapeutische Umschau. Revue therapeutique, 79(5), pp. 247-253. Huber 10.1024/0040-5930/a001358
Diem, Lara; Fregolente-Gomes, Livia; Warncke, Jan D; Hammer, Helly; Friedli, Christoph; Kamber, Nicole; Jung, Simon; Bigi, Sandra; Funke-Chambour, Manuela; Chan, Andrew; Bassetti, Claudio L; Salmen, Anke; Hoepner, Robert (2022). Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19. Journal of central nervous system disease, 14, p. 11795735221102727. Sage 10.1177/11795735221102727
Pistor, Maximilian; Hammer, Helly; Salmen, Anke; Hoepner, Robert; Friedli, Christoph (2022). Application of the "risk of ambulatory disability" (RoAD) score in a "real-world" single-center multiple sclerosis cohort. CNS neuroscience & therapeutics, 28(5), pp. 792-795. Wiley 10.1111/cns.13806
Hammer, Helly; Hoepner, Robert; Friedli, Christoph; Leib, Stephen L; Suter-Riniker, Franziska; Diem, Lara; Kamber, Nicole; Chan, Andrew; Salmen, Anke; Kamm, Christian P (2022). Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients. Vaccines, 10(6), p. 922. MDPI 10.3390/vaccines10060922
Diem, Lara; Hammer, Helly; Hoepner, Robert; Pistor, Max; Remlinger, Jana; Salmen, Anke (2022). Sex and gender differences in autoimmune demyelinating CNS disorders: Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin-oligodendrocyte-glycoprotein antibody associated disorder (MOGAD). International Review of Neurobiology, 164, pp. 129-178. 10.1016/bs.irn.2022.06.011
Bicvic, Antonela; Hammer, Helly; Sarikaya, Hakan; Heldner, Mirjam R. (2021). [Healthy diet in primary and secondary prevention of stroke]. Therapeutische Umschau, 78(6), pp. 259-268. Hogrefe 10.1024/0040-5930/a001270
Friedli, Christoph; Diem, Lara; Hammer, Helly; Kamber, Nicole; Suter-Riniker, Franziska; Leib, Stephen; Chan, Andrew; Hirzel, Cédric; Hoepner, Robert; Salmen, Anke (2021). Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies. Therapeutic advances in neurological disorders, 14, p. 17562864211016641. Sage 10.1177/17562864211016641
Hammer, Helly Noemi; Salmen, Anke (March 2023). Abklärung der primären ZNS-Vaskulitis. Rheuma Schweiz Fachzeitschrift
Hammer, H; Salmen, A; Kamber, N; Friedli, Chr; Diem, L; Hoepner, R; Chan, A (January 2022). Primäre ZNS-Vaskulitis. Rheuma Schweiz Fachzeitschrift, 2022(1), pp. 46-54.
Gonzalez-Machorro, Monica; Hecker, Pascal; Reichel, Uwe; Hammer, Helly N.; Hoepner, Robert; Pedrotti, Lisa; Zmutt, Alisha; Sagha, Hesam; Beek, Johan van; Eyben, Florian; Schuller, Dagmar M.; Schuller, Björn W.; Arnrich, Bert (2023). Towards Supporting an Early Diagnosis of Multiple Sclerosis using Vocal Features. In: INTERSPEECH 2023 (pp. 1518-1522). ISCA: ISCA 10.21437/Interspeech.2023-1759
